Literature DB >> 18467953

Postmenopausal status according to years since menopause as an independent risk factor for the metabolic syndrome.

Geum Joon Cho1, Jong Hyun Lee, Hyun Tae Park, Jung Ho Shin, Soon Cheol Hong, Tak Kim, Jun Young Hur, Kyu Wan Lee, Yong Kyun Park, Sun Haeng Kim.   

Abstract

OBJECTIVE: Features of the metabolic syndrome such as abdominal adiposity, insulin resistance, and dyslipidemia develop with the transition from pre- to postmenopausal status in women. We investigated the effects of postmenopausal status on the prevalence of the metabolic syndrome according to years since menopause.
DESIGN: We studied 1,002 women, 618 premenopausal and 384 postmenopausal, who participated in annual health examinations at Anam Hospital in Seoul, Korea.
RESULTS: Using multivariate logistic regression analysis, we determined that postmenopausal status was an independent risk factor for the metabolic syndrome. Moreover, after controlling for age and body mass index, postmenopausal women had an increased risk of the metabolic syndrome (odds ratio, 2.93; 95% CI, 1.62-5.33) and the abnormalities of its individual components. The risk for the metabolic syndrome increased up to 14 years since menopause, then decreased. For its individual components, postmenopausal women with 5 to 9 years since menopause had the highest risk of high blood pressure; postmenopausal women with less than 5 years since menopause had an increased risk of abdominal obesity and high glucose. With 10 to 14 years since menopause, postmenopausal women had an increased risk of high triglycerides.
CONCLUSIONS: Postmenopausal status is an independent risk factor for the metabolic syndrome and all of its individual components. The risk for the metabolic syndrome increased up to 14 years since menopause. In addition, postmenopausal status has effects during different periods since menopause for each of these components.

Entities:  

Mesh:

Year:  2008        PMID: 18467953     DOI: 10.1097/gme.0b013e3181559860

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  32 in total

Review 1.  Vascular effects of estrogenic menopausal hormone therapy.

Authors:  Ossama M Reslan; Raouf A Khalil
Journal:  Rev Recent Clin Trials       Date:  2012-02

2.  Urinary isoflavonoids and risk of type 2 diabetes: a prospective investigation in US women.

Authors:  Ming Ding; Adrian A Franke; Bernard A Rosner; Edward Giovannucci; Rob M van Dam; Shelley S Tworoger; Frank B Hu; Qi Sun
Journal:  Br J Nutr       Date:  2015-09-15       Impact factor: 3.718

3.  Resistance exercise and lipoproteins in postmenopausal women.

Authors:  J S Wooten; M D Phillips; J B Mitchell; R Patrizi; R N Pleasant; R M Hein; R D Menzies; J J Barbee
Journal:  Int J Sports Med       Date:  2010-11-17       Impact factor: 3.118

4.  [Incidence and Risk Factors of Dyslipidemia after Menopause].

Authors:  Ihn Sook Jeong; Hae Sun Yun; Myo Sung Kim; Youn Sun Hwang
Journal:  J Korean Acad Nurs       Date:  2022-04       Impact factor: 0.984

5.  Nutritional correlates and dynamics of diabetes in the Nile rat (Arvicanthis niloticus): a novel model for diet-induced type 2 diabetes and the metabolic syndrome.

Authors:  Fadi Chaabo; Andrzej Pronczuk; Ekaterina Maslova; Kc Hayes
Journal:  Nutr Metab (Lond)       Date:  2010-04-15       Impact factor: 4.169

6.  Interaction of metabolic syndrome with asthma in postmenopausal women: role of adipokines.

Authors:  Murat Aydin; Cemile Koca; Duygu Ozol; Sema Uysal; Zeki Yildirim; Havva Sahin Kavakli; M Ramazan Yigitoglu
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

7.  Estrogen improved metabolic syndrome through down-regulation of VEGF and HIF-1α to inhibit hypoxia of periaortic and intra-abdominal fat in ovariectomized female rats.

Authors:  Jinwen Xu; Qiuling Xiang; Guiping Lin; Xiaodong Fu; Kewen Zhou; Ping Jiang; Shuhui Zheng; Tinghuai Wang
Journal:  Mol Biol Rep       Date:  2012-05-09       Impact factor: 2.316

8.  The Relationship Between Menopause and Metabolic Syndrome: Experimental and Bioinformatics Analysis.

Authors:  Abir Jaballah; Ismael Soltani; Wael Bahia; Azza Dandana; Yosra Hasni; Abdelhedi Miled; Salima Ferchichi
Journal:  Biochem Genet       Date:  2021-05-10       Impact factor: 1.890

9.  Risk Factors of Metabolic Syndrome among Polish Nurses.

Authors:  Anna Bartosiewicz; Edyta Łuszczki; Małgorzata Nagórska; Łukasz Oleksy; Artur Stolarczyk; Katarzyna Dereń
Journal:  Metabolites       Date:  2021-04-23

10.  Aging and changes in adiposity indices: the impact of menopause.

Authors:  M Farahmand; M Bahri Khomamid; M Rahmati; F Azizi; F Ramezani Tehrani
Journal:  J Endocrinol Invest       Date:  2021-07-13       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.